Numerous angiogenic growth factors such as VEGF, fibroblast growth factor (FGF), and hepatocyte growth factor (HGF) have been extensively studied for treating ischemic diseases such as PAD and CHD [25] (Tables 1 and 2 contain a partial list of the preclinical and clinical studies mentioned below). The gene discussed is HGF; the disease is peripheral arterial disease.